Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 26, 2025 | (Q2)Jun 27, 2025 | (Q1)Mar 28, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 27, 2024 | (Q2)Jun 28, 2024 | (Q1)Mar 29, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -62.91%56M | -24.60%285M | -80.49%-74M | 26.53%663M | 82.29%175M | -57.46%151M | 39.48%378M | 79.29%-41M | -76.26%524M | -34.69%96M |
| Net income from continuing operations | -145.78%-204M | -122.86%-24M | 20.00%42M | 97.01%-5M | 59.48%-62M | -152.20%-83M | 180.15%105M | 183.33%35M | -108.46%-167M | -64.52%-153M |
| Operating gains losses | -82.14%5M | 7.14%15M | -4.55%21M | 9.86%78M | -68.09%15M | 115.38%28M | 55.56%14M | 340.00%22M | -5.33%71M | 88.00%47M |
| Depreciation and amortization | -2.21%133M | -2.90%134M | -2.90%134M | 1.85%550M | 2.22%138M | 3.03%136M | 2.22%138M | 0.00%138M | -8.32%540M | -8.78%135M |
| Asset impairment expenditure | --0 | --0 | --0 | -62.56%73M | 32.08%70M | --0 | -96.12%5M | ---2M | 282.35%195M | 39.47%53M |
| Deferred tax | -220.00%-16M | -155.88%-19M | 66.67%25M | 150.00%53M | 114.81%8M | -266.67%-5M | 200.00%34M | 171.43%15M | -120.42%-106M | -260.00%-54M |
| Other non cashItems | 10.00%-18M | 45.00%-22M | 16.67%7M | -1,620.00%-76M | -124.73%-23M | 62.96%-20M | -11.11%-40M | --6M | 106.67%5M | 9,200.00%93M |
| Change In working capital | 92.50%154M | 48.36%181M | 8.73%-230M | -236.36%-15M | 1,650.00%35M | 11.11%80M | -41.90%122M | 7.69%-252M | -80.00%11M | -97.14%2M |
| -Change in receivables | -25.71%26M | 2,066.67%65M | -6.38%-100M | -16.67%5M | 11.11%60M | 800.00%35M | -95.38%3M | 12.15%-94M | -95.71%6M | -63.76%54M |
| -Change in inventory | 27.66%60M | 16.97%193M | -30.41%-193M | -91.67%11M | -73.33%-52M | 14.63%47M | -26.99%165M | -40.95%-148M | 560.00%132M | -1,600.00%-30M |
| -Change in prepaid assets | 1,300.00%12M | -37.50%-33M | -20.00%4M | 0.00%4M | -7.69%24M | -150.00%-1M | 20.00%-24M | -16.67%5M | 166.67%4M | 52.94%26M |
| -Change in payables and accrued expense | 5,700.00%56M | -100.00%-44M | 493.33%59M | 73.28%-35M | 106.25%3M | -102.94%-1M | 56.86%-22M | 77.61%-15M | -32.32%-131M | 51.02%-48M |
| Tax refund paid | -71.43%4M | --20M | -2,366.67%-74M | 112.50%3M | 70.37%-8M | -17.65%14M | --0 | 40.00%-3M | 97.56%-24M | 0.00%-27M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -61.33%58M | -24.60%285M | -82.93%-75M | 25.90%661M | 80.21%173M | -57.75%150M | 38.97%378M | 79.29%-41M | -76.21%525M | -34.69%96M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 15.79%-80M | -346.43%-69M | 6.60%-99M | 40.00%-318M | 40.33%-145M | 7.77%-95M | 129.47%28M | -19.10%-106M | -15.47%-530M | -74.82%-243M |
| Net PPE purchase and sale | 15.89%-90M | 23.53%-78M | 14.75%-104M | -2.10%-487M | 0.64%-156M | 6.96%-107M | 3.77%-102M | -23.23%-122M | 0.00%-477M | -5.37%-157M |
| Net business purchase and sale | --0 | --0 | --0 | 224.00%124M | --0 | --0 | --119M | --5M | ---100M | ---100M |
| Interest received (cash flow from investment activities) | -50.00%6M | -27.27%8M | -45.45%6M | -8.51%43M | -21.43%11M | 0.00%12M | 0.00%11M | 10.00%11M | 176.47%47M | 55.56%14M |
| Net other investing changes | --3M | ---- | ---1M | --2M | --1M | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 14.74%-81M | -350.00%-70M | 6.60%-99M | 40.00%-318M | 40.50%-144M | 8.65%-95M | 129.47%28M | -19.10%-106M | -15.47%-530M | -74.10%-242M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -5.71%-74M | 129.36%32M | -118.92%-81M | -117.16%-582M | -117.96%-364M | -125.81%-70M | -179.49%-109M | -15.63%-37M | 87.39%-268M | 5.11%-167M |
| Net issuance payments of debt | 25.00%-3M | 3,300.00%96M | 0.00%-4M | -2,000.00%-315M | -7,525.00%-305M | -33.33%-4M | 40.00%-3M | 0.00%-4M | -7.14%-15M | ---4M |
| Net common stock issuance | -5.26%-40M | 52.11%-34M | -666.67%-46M | -7.75%-139M | 82.17%-23M | ---38M | ---71M | ---6M | 93.52%-129M | 8.51%-129M |
| Cash dividends paid | 3.85%-25M | -4.17%-25M | -8.33%-26M | -1.00%-101M | -4.00%-26M | -4.00%-26M | 4.00%-24M | 4.00%-24M | -1.01%-100M | 0.00%-25M |
| Interest paid (cash flow from financing activities) | -200.00%-6M | 54.55%-5M | -66.67%-5M | -12.50%-27M | -11.11%-10M | 33.33%-2M | -22.22%-11M | 0.00%-3M | -4.35%-24M | 10.00%-9M |
| Net other financing activities | ---1M | ---- | 200.00%1M | ---- | ---- | ---- | ---1M | ---1M | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -7.14%-75M | 129.09%32M | -110.53%-80M | -117.16%-582M | -118.56%-365M | -125.81%-70M | -182.05%-110M | -18.75%-38M | 87.39%-268M | 5.11%-167M |
| Net cash flow | ||||||||||
| Beginning cash position | -35.66%646M | -45.15%390M | -28.78%641M | -22.55%900M | -17.19%997M | 1.01%1B | -16.06%711M | -22.55%900M | -25.89%1.16B | -8.99%1.2B |
| Current changes in cash | -560.00%-99M | -16.55%247M | -37.30%-254M | 12.50%-238M | -7.37%-335M | -106.82%-15M | 114.49%296M | 41.82%-185M | 28.04%-272M | -85.71%-312M |
| Effect of exchange rate changes | -112.50%-1M | 400.00%9M | 175.00%3M | -310.00%-21M | -362.50%-21M | 180.00%8M | -133.33%-3M | -233.33%-4M | 135.71%10M | 14.29%8M |
| End cash Position | -45.24%546M | -35.66%646M | -45.15%390M | -28.78%641M | -28.78%641M | -17.19%997M | 1.01%1B | -16.06%711M | -22.55%900M | -22.55%900M |
| Free cash from | -174.42%-32M | -25.00%207M | -9.82%-179M | 262.50%174M | 127.87%17M | -82.08%43M | 66.27%276M | 45.12%-163M | -97.23%48M | -2,950.00%-61M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.